Balter Invenomic Fund Market Value

BIVIX Fund  USD 17.61  0.12  0.69%   
Balter Invenomic's market value is the price at which a share of Balter Invenomic trades on a public exchange. It measures the collective expectations of Balter Invenomic Fund investors about its performance. Balter Invenomic is trading at 17.61 as of the 2nd of December 2024; that is 0.69 percent up since the beginning of the trading day. The fund's open price was 17.49.
With this module, you can estimate the performance of a buy and hold strategy of Balter Invenomic Fund and determine expected loss or profit from investing in Balter Invenomic over a given investment horizon. Check out Balter Invenomic Correlation, Balter Invenomic Volatility and Balter Invenomic Alpha and Beta module to complement your research on Balter Invenomic.
Symbol

Please note, there is a significant difference between Balter Invenomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balter Invenomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balter Invenomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Balter Invenomic 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Balter Invenomic's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Balter Invenomic.
0.00
06/05/2024
No Change 0.00  0.0 
In 5 months and 30 days
12/02/2024
0.00
If you would invest  0.00  in Balter Invenomic on June 5, 2024 and sell it all today you would earn a total of 0.00 from holding Balter Invenomic Fund or generate 0.0% return on investment in Balter Invenomic over 180 days. Balter Invenomic is related to or competes with Qs Global, Mirova Global, Franklin Mutual, Scharf Global, Ab Global, and Doubleline Global. The fund invests primarily in both long and short positions in equity securities principally traded in United States mar... More

Balter Invenomic Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Balter Invenomic's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Balter Invenomic Fund upside and downside potential and time the market with a certain degree of confidence.

Balter Invenomic Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Balter Invenomic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Balter Invenomic's standard deviation. In reality, there are many statistical measures that can use Balter Invenomic historical prices to predict the future Balter Invenomic's volatility.
Hype
Prediction
LowEstimatedHigh
16.8517.4918.13
Details
Intrinsic
Valuation
LowRealHigh
15.6216.2619.24
Details
Naive
Forecast
LowNextHigh
16.8217.4618.10
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
16.9817.3417.69
Details

Balter Invenomic Backtested Returns

Balter Invenomic secures Sharpe Ratio (or Efficiency) of -0.058, which signifies that the fund had a -0.058% return per unit of risk over the last 3 months. Balter Invenomic Fund exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Balter Invenomic's Mean Deviation of 0.5436, standard deviation of 0.6593, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The fund shows a Beta (market volatility) of -0.11, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Balter Invenomic are expected to decrease at a much lower rate. During the bear market, Balter Invenomic is likely to outperform the market.

Auto-correlation

    
  0.40  

Average predictability

Balter Invenomic Fund has average predictability. Overlapping area represents the amount of predictability between Balter Invenomic time series from 5th of June 2024 to 3rd of September 2024 and 3rd of September 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Balter Invenomic price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Balter Invenomic price fluctuation can be explain by its past prices.
Correlation Coefficient0.4
Spearman Rank Test0.19
Residual Average0.0
Price Variance0.06

Balter Invenomic lagged returns against current returns

Autocorrelation, which is Balter Invenomic mutual fund's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Balter Invenomic's mutual fund expected returns. We can calculate the autocorrelation of Balter Invenomic returns to help us make a trade decision. For example, suppose you find that Balter Invenomic has exhibited high autocorrelation historically, and you observe that the mutual fund is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Balter Invenomic regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Balter Invenomic mutual fund is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Balter Invenomic mutual fund is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Balter Invenomic mutual fund over time.
   Current vs Lagged Prices   
       Timeline  

Balter Invenomic Lagged Returns

When evaluating Balter Invenomic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Balter Invenomic mutual fund have on its future price. Balter Invenomic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Balter Invenomic autocorrelation shows the relationship between Balter Invenomic mutual fund current value and its past values and can show if there is a momentum factor associated with investing in Balter Invenomic Fund.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Balter Mutual Fund

Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
CEOs Directory
Screen CEOs from public companies around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing